5-(3-chlorophenyl)-1,3-diphenyl-1H-benzo[f][1,2,4]triazepine

ID: ALA3746152

Chembl Id: CHEMBL3746152

PubChem CID: 57339459

Max Phase: Preclinical

Molecular Formula: C26H18ClN3

Molecular Weight: 407.90

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Clc1cccc(C2=NC(c3ccccc3)=NN(c3ccccc3)c3ccccc32)c1

Standard InChI:  InChI=1S/C26H18ClN3/c27-21-13-9-12-20(18-21)25-23-16-7-8-17-24(23)30(22-14-5-2-6-15-22)29-26(28-25)19-10-3-1-4-11-19/h1-18H

Standard InChI Key:  HABUESJKLQNHHO-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.90Molecular Weight (Monoisotopic): 407.1189AlogP: 6.69#Rotatable Bonds: 3
Polar Surface Area: 27.96Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.33CX LogP: 7.34CX LogD: 7.34
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.37Np Likeness Score: -0.78

References

1. Maqbool M, Mobashir M, Hoda N..  (2016)  Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.,  107  [PMID:26562543] [10.1016/j.ejmech.2015.10.018]

Source